Feedback / Questions
CB-011 - Caribou Biosci
https://www.globenewswire.com/news-release/2022/04/08/2419474/0/en/Caribou-Biosciences-Presents-Positive-Preclinical-Data-for-Allogeneic-Anti-BCMA-CAR-T-Cell-Therapy-Candidate-CB-011-at-the-American-Association-for-Cancer-Research-AACR-Annual-Meet.html
Apr 8, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next